These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31411124)

  • 1. Identification of potential histone deacetylase1 (HDAC1) inhibitors using multistep virtual screening approach including SVM model, pharmacophore modeling, molecular docking and biological evaluation.
    Krishna S; Lakra AD; Shukla N; Khan S; Mishra DP; Ahmed S; Siddiqi MI
    J Biomol Struct Dyn; 2020 Jul; 38(11):3280-3295. PubMed ID: 31411124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel hit compounds as potential HDAC1 inhibitors: The case of ligand- and structure-based virtual screening.
    Sirous H; Campiani G; Calderone V; Brogi S
    Comput Biol Med; 2021 Oct; 137():104808. PubMed ID: 34478925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined pharmacophore modeling, 3D-QSAR and docking studies to identify novel HDAC inhibitors using drug repurposing.
    Liu J; Zhu Y; He Y; Zhu H; Gao Y; Li Z; Zhu J; Sun X; Fang F; Wen H; Li W
    J Biomol Struct Dyn; 2020 Feb; 38(2):533-547. PubMed ID: 30938574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple Machine Learning Based-Chemoinformatics Models for Identification of Histone Acetyl Transferase Inhibitors.
    Krishna S; Kumar S; Singh DK; Lakra AD; Banerjee D; Siddiqi MI
    Mol Inform; 2018 Aug; 37(8):e1700150. PubMed ID: 29683269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacophore-based virtual screening, 3D QSAR, Docking, ADMET, and MD simulation studies: An in silico perspective for the identification of new potential HDAC3 inhibitors.
    Lanka G; Begum D; Banerjee S; Adhikari N; P Y; Ghosh B
    Comput Biol Med; 2023 Nov; 166():107481. PubMed ID: 37741229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated support vector machine and pharmacophore based virtual screening driven identification of thiophene carboxamide scaffold containing compound as potential PARP1 inhibitor.
    Singh M; Rajawat J; Kuldeep J; Shukla N; Mishra DP; Siddiqi MI
    J Biomol Struct Dyn; 2022 Nov; 40(18):8494-8507. PubMed ID: 33950778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic-based cancer therapeutics: new potential HDAC8 inhibitors.
    Hassanzadeh M; Mahernia S; Caprini G; Fossati G; Adib M; Moakedi F; Amanlou M
    J Biomol Struct Dyn; 2022 Jan; 40(1):297-311. PubMed ID: 32886033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation study.
    Choubey SK; Jeyaraman J
    J Mol Graph Model; 2016 Nov; 70():54-69. PubMed ID: 27668885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An insight into selective and potent inhibition of histone deacetylase 8 through induced-fit docking, pharmacophore modeling and QSAR studies.
    Kashyap K; Kakkar R
    J Biomol Struct Dyn; 2020 Jan; 38(1):48-65. PubMed ID: 30633630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacophore-enabled virtual screening, molecular docking and molecular dynamics studies for identification of potent and selective histone deacetylase 8 inhibitors.
    Kashyap K; Kakkar R
    Comput Biol Med; 2020 Aug; 123():103850. PubMed ID: 32658783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel tumor necrosis factor-α (TNF-α) inhibitors from small molecule library screening for their therapeutic activity profiles against rheumatoid arthritis using target-driven approaches and binary QSAR models.
    Zaka M; Abbasi BH; Durdagi S
    J Biomol Struct Dyn; 2019 Jun; 37(9):2464-2476. PubMed ID: 30047845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of novel histone deacetylase 7 inhibitors through molecular docking followed by a combination of molecular dynamics simulations and ligand-based approach.
    Yuan Y; Hu Z; Bao M; Sun R; Long X; Long L; Li J; Wu C; Bao J
    J Biomol Struct Dyn; 2019 Sep; 37(15):4092-4103. PubMed ID: 30417746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacophore-based virtual screening of ZINC database, molecular modeling and designing new derivatives as potential HDAC6 inhibitors.
    Poonia P; Sharma M; Jha P; Chopra M
    Mol Divers; 2023 Oct; 27(5):2053-2071. PubMed ID: 36214962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unveiling critical structural features for effective HDAC8 inhibition: a comprehensive study using quantitative read-across structure-activity relationship (q-RASAR) and pharmacophore modeling.
    Khatun S; Dasgupta I; Islam R; Amin SA; Jha T; Dhaked DK; Gayen S
    Mol Divers; 2024 Aug; 28(4):2197-2215. PubMed ID: 38871969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxamic acid derivatives as selective HDAC3 inhibitors: computer-aided drug design strategies.
    Patel P; Shrivastava SK; Sharma P; Kurmi BD; Shirbhate E; Rajak H
    J Biomol Struct Dyn; 2024; 42(1):362-383. PubMed ID: 36995068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into structural features of HDAC1 and its selectivity inhibition elucidated by Molecular dynamic simulation and Molecular Docking.
    Sixto-López Y; Bello M; Correa-Basurto J
    J Biomol Struct Dyn; 2019 Feb; 37(3):584-610. PubMed ID: 29447615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of HDAC6 selective inhibitors: pharmacophore based virtual screening, molecular docking and molecular dynamics simulation.
    Yan G; Li D; Zhong X; Liu G; Wang X; Lu Y; Qin F; Guo Y; Duan S; Li D
    J Biomol Struct Dyn; 2021 Apr; 39(6):1928-1939. PubMed ID: 32178584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based design of selective histone deacetylase 6 zinc binding groups.
    Alves Avelar LA; Ruzic D; Djokovic N; Kurz T; Nikolic K
    J Biomol Struct Dyn; 2020 Jul; 38(11):3166-3177. PubMed ID: 31382868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing the Sensitivity of Pharmacophore-Based Virtual Screening by Incorporating Customized ZBG Features: A Case Study Using Histone Deacetylase 8.
    Hou X; Du J; Liu R; Zhou Y; Li M; Xu W; Fang H
    J Chem Inf Model; 2015 Apr; 55(4):861-71. PubMed ID: 25757142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computer-Driven Development of an in Silico Tool for Finding Selective Histone Deacetylase 1 Inhibitors.
    Sirous H; Campiani G; Brogi S; Calderone V; Chemi G
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32331470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.